The NEO Exchange (NEO) is Canada’s next generation stock exchange, putting the needs of investors, businesses looking to raise capital and dealers first. To learn more, or inquire about listing or trading on NEO, please contact NEO’s Investor Helpline at 1-84 (toll-free) or email NEO Exchange When shares begin trading on Wednesday under the ticker symbol HLTH, Nobilis Health ( will become the first cross-listed company on NEO.
We look forward to welcoming Nobilis Health back to Canada this week.” “Our stock exchange is designed to meet the needs of public companies like Nobilis Health who recognize both the opportunities the Canadian capital markets can bring to their growth strategy and the opportunities international companies can bring to Canadian investors and the Canadian economy as a whole.
“We believe that tangible, long-term benefits for global investors and international companies like Nobilis Health can be realized through a dual listing, and are proud that our commitment to doing things differently in the stock exchange business is what will rekindle their relationship with the Canadian capital markets,” added Jos Schmitt, President and Chief Executive Officer, NEO. Nobilis Health, a leading US healthcare development and management company with over 30 locations across Texas and Arizona, including hospitals, ambulatory surgery centres, multi-specialty clinics and partners with over 30 facilities across the country, generated over USD $285 million in revenue in 2016. We are excited about the impact this will have on our global shareholder base.” The first-rate service offered by NEO and their depth of knowledge have helped expedite this cross-listing process. NEO’s unique focus on quality liquidity and its investor outreach program will further the recognition of our true market value and allow us to grow our Canadian shareholder base. “Better access to and by investors, enabled by a dual listing in the US and Canada, will benefit our existing shareholders and our ability to raise capital in the future. “We are pleased to have received approval to list on NEO and are eagerly anticipating our return to the Canadian market,” stated Harry Fleming, Nobilis Health CEO and Chairman of the Board. Nobilis Health shares are expected to begin trading on NEO on March 7, 2018. Nobilis Health will be the first corporation to list its shares on both a US-based stock exchange and NEO. (NYSE American: HLTH) (“Nobilis Health”) has received final approval to list its common shares on NEO. Toronto – Ma– The NEO Exchange (“NEO”) is pleased to announce that Nobilis Health Corp. NEO Prepares to Welcome Its First Cross-Border Listing
0 kommentar(er)
